文档介绍：艾滋病疫苗
While the most promising AIDS ine trial ever took place in Thailand, Africa is playing a major role in AIDS ine research. The International AIDS ine Initiative (IAVI) works in partnership with African countries in researching the virus which has infected tens of millions of people on the continent.
"The benefits for Africa are immense," says h Stevens, director of the initiative's Clinical Laboratory Program for research and development in South Africa, "Today, IAVI supports and operates 11sophisticated clinical trial facilities in collaboration with local scientists and institutions in five countries in Africa. So currently, the countries make a huge contribution to the data that is generated."
The five countries are Kenya, Uganda, South Africa, Rwanda and Zambia.
Stevens adds that the sites generate valuable information on HIV prevalence and incidence, immunology and safety, as well as on the development of disease.
Do or die
The only real way to stop the AIDS epidemic is by developing a ine, Stevens says. There is no cure. While anti-retroviral drugs prolong lives, they still fail to rid the pletely of HIV.
She says while working toward that goal, IAVI is strengthening local and
national health care systems:
"While we're on route to the development of a ine, there are huge contributions that NGOs like ourselves, make to Africa. For example, ca